Skip to content

Safety and effectiveness of defocus custom lens for myopia control

Effectiveness of defocused customized lenses in delaying myopia progression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063012
Enrollment
Unknown
Registered
2022-08-27
Start date
2022-09-10
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ametropia

Interventions

Group 1 :Single vision spectacle lens
Group 2:Wear free surface lens custom glasses
Group 3:Wear the defocus custom lens set

Sponsors

Tianjin Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 8 years old and = 10 h/day) and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with dominant strabismus; 2. Abnormal intraocular pressure (intraocular pressure 21 mmHg or bilateral intraocular pressure difference >= 5 mmHg); 3. Patients with other eye diseases, such as uveitis and other inflammations, glaucoma, cataracts, fundus diseases, eye tumors, eye trauma; and any eye diseases that affect visual function; 4. Previous history of eye surgery; 5. Those who have participated in drug clinical trials within three months, or/and have used any myopia control products, such as rigid contact lenses, multifocal contact lenses, progressive multifocal lenses and other specially designed myopia control lenses, atropine drugs, etc.; 6. Patients with low immunity caused by systemic diseases (such as acute and chronic sinusitis, diabetes, Down's syndrome, rheumatoid arthritis, mental illness or other diseases that researchers believe are not suitable for glasses, etc.; 7. There is a relevant family history of genetic eye diseases; 8. Only one eye meets the selection criteria; 9. Those who cannot have regular eye examinations; 10. Other circumstances that the investigator judges to be inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
axial length;spherical equivalent;

Countries

China

Contacts

Public ContactLihua Li

Tianjin Eye Hospital

lilihua5081@vip.sina.com+86 22 27217663

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026